Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients

PURPOSE: Accumulating studies have investigated the prognostic and clinical significance of programmed death ligand-1 (PD-L1) expression in patients with hepatocellular carcinoma (HCC); however, the results were conflicting and inconclusive. We conducted a meta-analysis to combine controversial data...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Xiaobin, Gao, Xian-Shu, Xiong, Wei, Guo, Wei, Han, Linjun, Bai, Yun, Peng, Chuan, Cui, Ming, Xie, Mu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976917/
https://www.ncbi.nlm.nih.gov/pubmed/27536144
http://dx.doi.org/10.2147/OTT.S110713

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976917/
https://www.ncbi.nlm.nih.gov/pubmed/27536144
http://dx.doi.org/10.2147/OTT.S110713

Ejemplares similares